Biotech Values

[Titan V]

MRNS—Be Greedy When Others Are Fearful

https://seekingalpha.com/article/4153378-marinus-pharmaceuticals-greedy-others-fearful

• A much-anticipated readout in post-partum depression ('PPD') has been delayed, causing shareholder anxiety and a panicky selloff.

• The company is moving forward with a PhIII study of oral ganaxolone in CDKL5, an orphan pediatric indication.

• An upcoming study of ganaxolone IV as an adjunctive treatment in status epilepticus ('SE') has disruptive potential.

• Significant differentiation from Sage Therapeutics and a cautious approach to clinical development bode well for this small concern in the neuro space.

...